HwaGen Pharmaceutical

HwaGen Pharmaceutical is a China-based pharmaceutical technology company focused on CRO/CDMO services and the development and manufacturing of specialty active pharmaceutical ingredients and intermediates. Founded in late 2015 in Shenzhen, the company emphasizes chiral synthesis, enzymatic catalysis, and continuous-flow microreactor technologies to support both high-end generics and innovative drug programs. Its offerings appear to span process development, drug registration support, technology transfer, and commercial supply of difficult-to-make small-molecule APIs and intermediates. The company highlights work in oncology, antiviral, and respiratory disease-related products and services. HwaGen also appears to be building digital synthesis capabilities through a platform referred to as DeepSynth.